- Trials with a EudraCT protocol (3,018)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2,041)
3,018 result(s) found for: Neoplasm.
Displaying page 1 of 151.
EudraCT Number: 2012-005040-20 | Sponsor Protocol Number: 2012-520 | Start Date*: 2013-01-09 | |||||||||||
Sponsor Name:Rigshospitalet | |||||||||||||
Full Title: Effect of Macrodex versus lactated Ringer on coagulation in major surgery. A randomised clincal trial. | |||||||||||||
Medical condition: Neoplasma malignum vesicae urinaria | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003962-40 | Sponsor Protocol Number: S043VELC02 | Start Date*: 2006-03-22 | |||||||||||
Sponsor Name:FONDAZIONE SENDO | |||||||||||||
Full Title: An open label, Phase II study of biweekly VELCADETM and intermittent CAELIXTM in patients with ovarian cancer failing platinum containing regimens | |||||||||||||
Medical condition: ovarian cancer failing platinum containing regimens | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000329-31 | Sponsor Protocol Number: EORTC 22011- 40014 | Start Date*: 2004-09-15 | |||||||||||
Sponsor Name:E.O.R.T.C. - EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER | |||||||||||||
Full Title: Continuous fluorouracil plus mitomycin C versus mitomycin C plus Cisplatin as chemotherapy combination in combined radiochemotherapy for locally advanced anal cancer. A phase II-III study | |||||||||||||
Medical condition: Locally Advanced Anal Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-003342-29 | Sponsor Protocol Number: fotgm | Start Date*: 2007-10-31 | |||||||||||
Sponsor Name:ISTITUTI FISIOTERAPICI OSPITALIERI | |||||||||||||
Full Title: Second line therapy with low dose fotemustine in progressive malignant gliomas | |||||||||||||
Medical condition: Progressive malignant gliomas patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012225-12 | Sponsor Protocol Number: 64-Cu-ATSM-CC-02/2009 | Start Date*: 2009-09-15 | ||||||||||||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | ||||||||||||||||||||||||||||
Full Title: Role of 64Cu-ATSM PET/CT for the localization of hypoxic areas in head and neck cancer | ||||||||||||||||||||||||||||
Medical condition: head and neck cancer. MEDRA code has not been found. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000466-33 | Sponsor Protocol Number: PT/11/2015 | Start Date*: 2016-03-22 | |||||||||||
Sponsor Name:Department of Pediatric oncology, Aarhus University hospital | |||||||||||||
Full Title: Pharmacokinetics and pharmacodynamics of Piperacillin-Tazobactam (PT) in pediatric oncology patients with fever and neutropenia. | |||||||||||||
Medical condition: Pediatric oncology patients with fever and neutropenia | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-006449-14 | Sponsor Protocol Number: CHUBX2008/31 | Start Date*: 2009-02-13 | |||||||||||
Sponsor Name:CHU de Bordeaux | |||||||||||||
Full Title: Evaluation méthodologique de la tomographie par émission de positons couplée au scanner (TEP-TDM) au Fluoromisonidazole marqué au fluor 18 ([18F]-FMISO) dans l’évaluation de la réponse au traitemen... | |||||||||||||
Medical condition: Glioblastome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004749-41 | Sponsor Protocol Number: NEO-ONE | Start Date*: 2011-12-13 | |||||||||||
Sponsor Name:TweeSteden hospital | |||||||||||||
Full Title: The effects of neoadjuvant hormonal therapy on the course of PSA and testosterone in patients with low and intermediate-risk prostate carcinoma (NEO-ONE); A randomized controlled trial | |||||||||||||
Medical condition: Localized prostate cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-006411-20 | Sponsor Protocol Number: CHUBX 2008/20 | Start Date*: 2009-02-13 | |||||||||||
Sponsor Name:CHU de Bordeaux | |||||||||||||
Full Title: EVALUATION PRONOSTIQUE DE LA TOMOGRAPHIE PAR EMISSION DE POSITONS COUPLEE AU SCANNER (TEP-TDM) AU FLUOROMISONIDAZOLE MARQUE AU FLUOR 18 (18F-FMISO) DANS LES CANCERS EPIDERMOIDES DES VOIES AERODIGES... | |||||||||||||
Medical condition: CANCERS EPIDERMOIDES DES VOIES AERODIGESTIVES SUPERIEURES | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-007241-12 | Sponsor Protocol Number: PH-L19SIPI131-07/07 | Start Date*: 2008-10-06 | |||||||||||
Sponsor Name:Philogen S.p.A. | |||||||||||||
Full Title: A PHASE I/II DOSE FINDING AND EFFICACY STUDY OF THE TUMOUR TARGETING HUMAN 131I-L19SIP MONOCLONAL ANTIBODY IN PATIENTS WITH CANCER | |||||||||||||
Medical condition: Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-006796-80 | Sponsor Protocol Number: TES10897 | Start Date*: 2009-04-23 | |||||||||||
Sponsor Name:Sanofi-Aventis Recherche & Développement | |||||||||||||
Full Title: The QUTIE Study: A Randomized, Double-Blind, Placebo-controlled Study Comparing Aflibercept Versus Placebo on the QTc interval in Cancer Patients treated with Docetaxel | |||||||||||||
Medical condition: Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) DK (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005238-19 | Sponsor Protocol Number: CD-2007-01 | Start Date*: 2007-07-26 | |||||||||||
Sponsor Name:Instituto Cientifico y Tecnologico de Navarra | |||||||||||||
Full Title: Estudio fase II con inmunoterapia mediante células dendríticas y linfocitos infiltrantes de tumor en tumores sólidos | |||||||||||||
Medical condition: Melanoma, renal cell carcinoma, hepatocarcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001359-60 | Sponsor Protocol Number: Vasobrain01 | Start Date*: 2015-06-16 | |||||||||||
Sponsor Name:Aarhus University Hospital | |||||||||||||
Full Title: Influence of vasopressors on brain oxygenation and microcirculation in anesthetized patients with cerebral tumors | |||||||||||||
Medical condition: Brain oxygenation and microcirculation under administration of Efedrin and Metaoxedrin in patients with cerebral tumor. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022270-14 | Sponsor Protocol Number: 20101116 | Start Date*: 2011-02-11 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: Estudio abierto de extensión de fase 2 con conatumumab . A Phase 2 Open Label Extension Study of Conatumumab. | |||||||||||||
Medical condition: diferentes tumores sólidos, incluyendo, entre otros, cáncer colorrectal (CCR), cáncer de pulmón de células no pequeñas (CPCNP), sarcoma de tejidos blandos (STB), linfoma no Hodgkin (LNH), cáncer de... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004848-23 | Sponsor Protocol Number: 89/2006/O/Sper | Start Date*: 2006-09-12 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: Sequential Oral Therapy (SOT trial) in elderly patients with metastatic breast cancer: a phase IV randomized trial | |||||||||||||
Medical condition: breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-009418-42 | Sponsor Protocol Number: INT-07/09 | Start Date*: 2009-05-19 | |||||||||||
Sponsor Name:ISTITUTO NAZIONALE PER LA CURA TUMORI | |||||||||||||
Full Title: Phase II study evaluating efficacy and tolerability of Sorafenib in the treatment of iatrogenic lymphedema occurring in breast cancer patients following surgical dissection of, and/or radiotherapy ... | |||||||||||||
Medical condition: Breast cancer patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-007059-14 | Sponsor Protocol Number: GlutOxa2007 | Start Date*: 2007-11-15 | |||||||||||
Sponsor Name:AZIENDA DI RILIEVO NAZIONALE E DI ALTA SPECIALIZZAZIONE OSPEDALE CIVICO E BENFRATELLI, G.DI CRISTINA E M.ASCOLI | |||||||||||||
Full Title: Role of the Glutatione reduced in the prevention of neuro-toxicity from Oxaliplatino. | |||||||||||||
Medical condition: Patients with neoplasia malignant. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-007089-12 | Sponsor Protocol Number: 2606 B | Start Date*: 2007-02-07 | |||||||||||
Sponsor Name:GOIM GRUPPO ONCOLOGICO MERIDIONALE | |||||||||||||
Full Title: Liposomial pegylate doxorubicine and trasuzumab in the first line treatment of the metastatised Her2 positive breast cancer for senior women | |||||||||||||
Medical condition: Metastased breast cancer, first line treatment, for women with age>70 years old,Her2 positive | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001456-36 | Sponsor Protocol Number: EGF100151 | Start Date*: 2004-09-06 | |||||||||||
Sponsor Name:GLAXO SMITHKLINE | |||||||||||||
Full Title: A phase III, randomized, open-label, multicenter study comparing GW572016 and Capecitabile (Xeloda) versus Capecitabile in women with refractory advanced or metastatic breast cancer. | |||||||||||||
Medical condition: Solid tumor treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003752-38 | Sponsor Protocol Number: om 169 | Start Date*: 2003-12-09 | |||||||||||
Sponsor Name:OSPEDALE ONCOLOGICO DI BARI | |||||||||||||
Full Title: A phase II study of Capecitabine in combination with oral vinorelbine in advanced Breast Cancer | |||||||||||||
Medical condition: advancer breast carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.